SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-157067
Filing Date
2014-04-24
Accepted
2014-04-24 16:01:36
Documents
10
Period of Report
2014-05-22
Effectiveness Date
2014-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d689173ddef14a.htm DEF 14A 958202
3 GRAPHIC g689173corresp_logo.jpg GRAPHIC 15205
4 GRAPHIC g689173g26k16.jpg GRAPHIC 8679
5 GRAPHIC g689173g49c74.jpg GRAPHIC 8473
6 GRAPHIC g689173pc_pg01a.jpg GRAPHIC 32440
7 GRAPHIC g689173pc_pg01b.jpg GRAPHIC 45004
8 GRAPHIC g689173pc_pg01c.jpg GRAPHIC 1160
9 GRAPHIC g689173pc_pg01d.jpg GRAPHIC 1191
10 GRAPHIC g689173pc_pg01e.jpg GRAPHIC 17287
11 GRAPHIC g689173pc_pg01f.jpg GRAPHIC 40341
  Complete submission text file 0001193125-14-157067.txt   1194532
Mailing Address 350 MERRIMACK STREET LAWRENCE MA 01843
Business Address 350 MERRIMACK STREET LAWRENCE MA 01843 978-687-4700
NxStage Medical, Inc. (Filer) CIK: 0001333170 (see all company filings)

IRS No.: 043454702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51567 | Film No.: 14781733
SIC: 3845 Electromedical & Electrotherapeutic Apparatus